Functional Plasticity of Gamma Delta T Cells and Breast Tumor Targets in Hypoxia.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

29 citing papers in PubMed, 35 citations in OpenAlex.

1. Boosting T cell antioxidant capacity: A strategic approach to overcome immunosuppression in solid tumors.Redox biology · 2026
   Review
2. NKGD2 Ligands (NKG2DLs) in Breast Cancer: In Silico Analysis and Narrative Review.International journal of molecular sciences · 2026
   Review
3. Harnessing Vδ1Frontiers in immunology · 2026
   Review
4. Genome-edited allogeneic CAR-T cells: the next generation of cancer immunotherapies.Journal of hematology & oncology · 2025
   Review
5. Expanding Immunotherapy Beyond CAR T Cells: Engineering Diverse Immune Cells to Target Solid Tumors.Cancers · 2025
   Review
6. Application of mass cytometry in the immune microenvironment of breast cancer.Medical oncology (Northwood, London, England) · 2025
   Review
7. Spatial and Single-Cell Analyses Reveal Heterogeneity of DNAM-1 Receptor-Ligand Interactions That Instructs Intratumoral γδT-cell Activity.Cancer research · 2025
   Article
8. Exploring the Complexity and Promise of Tumor Immunotherapy in Drug Development.International journal of molecular sciences · 2024
   Review
9. CTLs heterogeneity and plasticity: implications for cancer immunotherapy.Molecular cancer · 2024
   Review
10. The Role of γδ T-Lymphocytes in Glioblastoma: Current Trends and Future Directions.Cancers · 2023
    Review
11. γδ T cells: origin and fate, subsets, diseases and immunotherapy.Signal transduction and targeted therapy · 2023
    Review
12. Challenges and new technologies in adoptive cell therapy.Journal of hematology & oncology · 2023
    Review
13. Atherosclerosis and Inflammation: Insights from the Theory of General Pathological Processes.International journal of molecular sciences · 2023
    Review
14. Gamma/delta T cells as cellular vehicles for anti-tumor immunity.Frontiers in immunology · 2023
    Review
15. Regulation of NKG2D Stress Ligands and Its Relevance in Cancer Progression.Cancers · 2022
    Review
16. Allogeneic CD20-targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B-cell lymphoma models.Clinical & translational immunology · 2022
    Article
17. The Diverse Roles of γδ T Cells in Cancer: From Rapid Immunity to Aggressive Lymphoma.Cancers · 2021
    Review
18. Metabolic Changes in Tumor Microenvironment: How Could They Affect γδ T Cells Functions?Cells · 2021
    Review
19. Biological bases of cancer immunotherapy.Expert reviews in molecular medicine · 2021
    Article
20. Antitumor γδ T cells need oxygen to function.Nature immunology · 2021
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as